Product news from the 04/14/06 News Brief
The FDA approved Alkermes and Cephalon’s Vivitrol (naltrexone for extended-release injectable suspension) for the treatment of alcohol dependence.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.